The global Cyclin-dependent Kinase (CDK) Inhibitors Market represents one of the most dynamic and high-growth segments within oncology therapeutics. CDKs are a family of enzymes that play a critical, rate-limiting role in regulating the cell cycle—the process by which cells grow and divide. In many cancers, this regulatory mechanism is hijacked, leading to uncontrolled proliferation. https://www.databridgemarketresearch.com/